Physician profile
James Ren
NPI 1447639505
$2,724.70
in general payments reported to CMS, 2019-2025
26 companies · $697 in 2025
The $697 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $437 · 2023: $829 · 2024: $545 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,071.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,113.52 | 2021-2025 | Endurant Iis, Venaseal, Interstim |
| Boston Scientific Corporation | $309.53 | 2023-2025 | Varithena Administration Pack, Enroute Transcarotid Stent, Eluvia |
| Janssen Pharmaceuticals, INC | $277.57 | 2023-2024 | Xarelto |
| Imperative Care, INC | $135.54 | 2025 | Symphony Catheter |
| Silk Road Medical, INC. | $129.63 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Surmodics, INC. | $115.93 | 2024 | Pounce Thrombectomy |
| Angiodynamics, INC. | $95.66 | 2022 | |
| Baxter Healthcare | $53.59 | 2024 | Renal - Chronic |
| Neuros Medical, INC. | $52.68 | 2025 | Altius |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.88 | 2022 | |
| Bone Support INC. | $46.23 | 2025 | Ceramentbone Void Filler, Cerament G |
| Penumbra, INC. | $46.14 | 2024-2025 | Ruby Coil, Indigo System |
| Bard Peripheral Vascular, INC. | $41.95 | 2022-2024 | Fluency Endovascular Stent Graft |
| Organogenesis INC. | $38.20 | 2024 | |
| Veryan Medical Incorporated | $28.10 | 2023 | Biomimics 3d Vascular Stent System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $21.72 | 2024 | Gore Excluder Iliac Branch Endoprosthesis |
| Mozarc Medical US LLC | $21.49 | 2024 | Permcath |
| E.R. Squibb & Sons, L.L.C. | $21.27 | 2024 | Eliquis |
| Cardiva Medical, INC. | $19.65 | 2025 | Cardiva Vascade 5f Vcs |
| Reflow Medical INC | $16.51 | 2025 | |
| Flowphysix INC | $16.25 | 2025 | Flowrunner |
| Argon Medical Devices, INC. | $15.98 | 2025 | Clot Management |
| Lemaitre Vascular, INC. | $15.07 | 2023 | Artegraft Vascular Graft |
| Terumo Medical Corporation | $14.73 | 2024 | Azur Cx Detachable, Glidewire |
| Acera Surgical, INC. | $14.11 | 2025 | Restrata Wound Matrix |
| Cardiovascular Systems INC. | $11.77 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.